<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" open-status="O" article-type="research-article" xml:lang="EN"><?properties no_embargo?><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Med Genet</journal-id><journal-id journal-id-type="publisher-id">jmg</journal-id><journal-title>Journal of Medical Genetics</journal-title><issn pub-type="ppub">0022-2593</issn><issn pub-type="epub">1468-6244</issn><publisher><publisher-name>BMJ Publishing Group</publisher-name><publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">2643051</article-id><article-id pub-id-type="publisher-id">mg54270</article-id><article-id pub-id-type="doi">10.1136/jmg.2007.054270</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>1506</subject><subject>1507</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="1982" pm="."><plain>Inherited mitochondrial optic neuropathies </plain></SENT>
</text></SecTag></article-title><alt-title alt-title-type="running-head">Review</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yu-Wai-Man</surname><given-names>P</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Griffiths</surname><given-names>P G</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Hudson</surname><given-names>G</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Chinnery</surname><given-names>P F</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Mitochondrial Research Group, The Medical School, Newcastle University, Newcastle upon Tyne, UK</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Department of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne, UK</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Institute of Human Genetics, Newcastle University, Newcastle upon Tyne, NE1 3BZ, UK</addr-line></aff><author-notes><corresp>Correspondence to: Professor P F Chinnery, Mitochondrial Research Group, The Medical School, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK; <email>P.F.Chinnery@ncl.ac.uk</email></corresp></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="ppub"><month>3</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>17</day><month>11</month><year>2008</year></pub-date><pub-date pub-type="pmc-release"><day>1</day><month>3</month><year>2009</year></pub-date><volume>46</volume><issue>3</issue><fpage>145</fpage><lpage>158</lpage><history><date date-type="received"><day>8</day><month>9</month><year>2008</year></date><date date-type="rev-recd"><day>8</day><month>9</month><year>2008</year></date><date date-type="accepted"><day>7</day><month>10</month><year>2008</year></date></history><permissions><copyright-statement>© Yu-Wai-Man et al 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="openaccess" xlink:href="http://creativecommons.org/licenses/by/2.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="1983" pm="."><plain>Leber hereditary optic neuropathy (LHON) and autosomal dominant optic atrophy (DOA) are the two most common inherited optic neuropathies and they result in significant visual morbidity among young adults. </plain></SENT>
<SENT sid="1984" pm="."><plain>Both disorders are the result of mitochondrial dysfunction: LHON from primary mitochondrial DNA (mtDNA) mutations affecting the respiratory chain complexes; and the majority of DOA families have mutations in the OPA1 gene, which codes for an inner mitochondrial membrane protein critical for mtDNA maintenance and oxidative phosphorylation. </plain></SENT>
<SENT sid="1985" pm="."><plain>Additional genetic and environmental factors modulate the penetrance of LHON, and the same is likely to be the case for DOA which has a markedly variable clinical phenotype. </plain></SENT>
<SENT sid="1986" pm="."><plain>The selective vulnerability of retinal ganglion cells (RGCs) is a key pathological feature and understanding the fundamental mechanisms that underlie RGC loss in these disorders is a prerequisite for the development of effective therapeutic strategies which are currently limited. </plain></SENT>
</text></SecTag></p></abstract></article-meta></front><body><p><text><SENT sid="1987" pm="."><plain>Mitochondrial disorders are a major cause of chronic human disease with an estimated prevalence of 1 in 10 000 in the UK and a further 1 in 200 individuals being at-risk mutational carriers.1 2 Ocular involvement is a prominent feature in this group and often points towards the underlying mitochondrial aetiology, which allows for a more targeted diagnostic approach. </plain></SENT>
<SENT sid="1988" pm="."><plain>Optic nerve dysfunction can be the presenting and only ophthalmological manifestation causing the two most common inherited optic neuropathies encountered in clinical practice, Leber hereditary optic neuropathy (LHON) and autosomal dominant optic atrophy (DOA), which are the focus of this review. </plain></SENT>
<SENT sid="1989" pm="."><plain>In the majority of cases, the pathology in LHON and DOA is limited to a highly specialised group of cells within the eye, the retinal ganglion cells (RGCs), but the phenotype associated with these two conditions is expanding, providing important insights into possible disease pathways leading to optic nerve degeneration and visual failure. </plain></SENT>
</text></p><sec id="s2"><title><text><SENT sid="1990" pm="."><plain>LEBER HEREDITARY OPTIC NEUROPATHY </plain></SENT>
</text></title><sec id="s2a"><title><text><SENT sid="1991" pm="."><plain>LHON mutations </plain></SENT>
</text></title><p><text><SENT sid="1992" pm="."><plain>LHON (OMIM 535000) was first described as a distinctive clinical entity in 1871 by the German ophthalmologist Theodore Leber (1840–1917).3 He reported a characteristic pattern of visual loss among members of four families and his observations were subsequently confirmed in pedigrees from different populations.4–6 These early studies highlighted several of the salient features of LHON including the maternal transmission of the disease, the predilection of males to lose vision, and the almost exclusive involvement of the optic nerve. </plain></SENT>
<SENT sid="1993" pm="."><plain>The non-Mendelian pattern of inheritance was only fully explained in 1988 when LHON became the first human disease proven to be caused by a point mutation (m.11778G&gt;A) within the mitochondrial genome.7 Over 95% of LHON pedigrees are now known to harbour one of three mitochondrial DNA (mtDNA) point mutations: m.3460G&gt;A, m.11778G&gt;A and m.14484T&gt;C, which all involve genes encoding complex I subunits of the mitochondrial respiratory chain.8 In a meta-analysis of 159 pedigrees from Northern Europe and Australia, m.11778G&gt;A was the most prevalent mutation but there is considerable variation in the relative frequency of these three primary LHON mutations worldwide (table 1). </plain></SENT>
<SENT sid="1994" pm="."><plain>The predominance of m.11778G&gt;A is even more pronounced in the Far East where it accounts for ∼90% of all cases,9 10 and although m.14484T&gt;C is relatively rare, it is the most common mutation found among French Canadians (87%) as a result of a founder event.11 12 Primary mutations have not been identified in a small minority of clinically diagnosed LHON patients, the most likely explanation being that rare pathogenic mtDNA variants are segregating in these families.13 Disease causing mutations have been identified in a proportion of these cases, while other putative LHON mutations require further confirmation as they have only been found in singletons or a single family (table 1). </plain></SENT>
</text></p><SecTag type="TABLE"></SecTag><p><text><SENT sid="2333" pm="."><plain>Glaucoma is the second most common cause of blindness in developed countries and accounts for about 10% of all blind registration in the UK.205 It is a primary, acquired optic neuropathy with a strong genetic component and OPA1 mutations have been identified in a number of patients initially diagnosed with normal tension glaucoma, highlighting the similarities in optic disc features shared with DOA.206 207 It is of note therefore that some studies have shown an association between the risk of developing glaucoma and certain OPA1 polymorphic variants,208–210 with other investigators reporting mtDNA abnormalities in their glaucoma cohorts, such as an increased mtDNA copy number and reduced respiratory chain activities in peripheral blood lymphocytes.211 Although further studies are needed, these findings suggest a possible mitochondrial influence on the pathogenesis of glaucoma. </plain></SENT>
</text></p></sec><sec id="s5"><title><text><SENT sid="2334" pm="."><plain>UNIFYING HYPOTHESIS </plain></SENT>
</text></title><p><text><SENT sid="2335" pm="."><plain>The common theme in the various optic neuropathies described in this review is the vulnerability of RGCs to mitochondrial dysfunction. </plain></SENT>
<SENT sid="2336" pm="."><plain>Although there is a high level of mitochondrial enzyme activity in RGCs,212 this phenomenon cannot be explained by a simple energetic deficit since photoreceptors have a much higher oxidative demand than RGCs and other mitochondrial disorders characterised by more severe complex I defects do not universally cause optic atrophy. </plain></SENT>
<SENT sid="2337" pm="."><plain>It is possible that RGCs are preferentially involved because they are more sensitive to subtle imbalances in cellular redox state or increased ROS levels, but an attractive hypothesis implicates the differential mitochondrial concentration observed at the lamina cribosa.213 The lamina cribosa is a perforated collagen plate that marks the anatomical transition from the unmyelinated (pre-laminar) to the myelinated (post-laminar) segment of the human optic nerve. </plain></SENT>
<SENT sid="2338" pm="."><plain>The pre-laminar section has a much higher concentration of mitochondria to support the higher energy demands of unmyelinated nerve conduction and it is likely that active processes involving the cytoskeletal architecture are needed to maintain this sharp mitochondrial gradient.214 215 Pathological mechanisms which disrupt this unique structural feature would lead to impaired axonal transport, as seen in CMT179 216 217 and HSP,218 219 and set up a vicious circle with fragmentation of the mitochondrial network at the lamina cribosa exacerbating even subtle mitochondrial energy deficits and eventually precipitating apoptotic cell death. </plain></SENT>
</text></p></sec><SecTag type="CONCL"><sec id="s6"><title><text><SENT sid="2339" pm="."><plain>CONCLUSION </plain></SENT>
</text></title><p><text><SENT sid="2340" pm="."><plain>LHON and DOA show an intriguing degree of clinical and mechanistic overlap, with both disorders caused by the selective degeneration of the RGC layer. </plain></SENT>
<SENT sid="2341" pm="."><plain>They are the two most common inherited optic neuropathies and they provide strong evidence that the maintenance of RGCs is heavily dependent upon normal mitochondrial function. </plain></SENT>
<SENT sid="2342" pm="."><plain>This is further substantiated by recent studies pointing towards a mitochondrial link in sporadic glaucoma and other genetic disorders where optic nerve dysfunction is a prominent clinical feature. </plain></SENT>
<SENT sid="2343" pm="."><plain>Although major advances have been achieved in the two decades since the primary LHON mutations were identified, several key questions remain unanswered. </plain></SENT>
<SENT sid="2344" pm="?"><plain>What secondary factors account for the notable incomplete penetrance and male bias in LHON? </plain></SENT>
<SENT sid="2345" pm="?"><plain>What explains the variable disease expression in DOA, and why is there no gender bias in this disorder, given the similarity to LHON? </plain></SENT>
<SENT sid="2346" pm="?"><plain>What are the causative nuclear genes in OPA1-negative families and will they also involve mitochondrial dysfunction? </plain></SENT>
<SENT sid="2347" pm="?"><plain>What mechanisms underpin the preferential loss of RGCs in these mitochondrial optic neuropathies? </plain></SENT>
<SENT sid="2348" pm="."><plain>The characterisation of recently developed animal models and future genetic and functional studies will hopefully reveal important pathophysiological pathways amenable to therapeutic interventions. </plain></SENT>
</text></p></sec></SecTag></body><back><SecTag type="ACK_FUND"><ack><p><text4fund><text><SENT sid="2349" pm="."><plain>PFC is a Wellcome Trust Senior Fellow in Clinical Science and PYWM is an MRC Clinical Research Fellow. </plain></SENT>
</text></text4fund></p></ack></SecTag><SecTag type="REF"><ref-list><title>REFERENCES</title><ref id="b1"><text><SENT sid="2350" pm="."><plain>1SchaeferAMMcFarlandRBlakelyELHeLWhittakerRGTaylorRWChinneryPFTurnbullDM Prevalence of mitochondrial DNA disease in adults.Ann Neurol2008;63:35–917886296 </plain></SENT>
</text></ref><ref id="b2"><text><SENT sid="2351" pm="."><plain>2ElliottHRSamuelsDCEdenJAReltonCLChinneryPF Pathogenic mitochondrial DNA mutations are common in the general population.Am J Hum Genet2008;83:254–6018674747 </plain></SENT>
</text></ref><ref id="b3"><text><SENT sid="2352" pm="."><plain>3LeberT Ueber hereditaere und congenital angelegte sehnervenleiden.Graefes Arch Opthal1871;17:249–91 </plain></SENT>
</text></ref><ref id="b4"><text><SENT sid="2353" pm="."><plain>4BellJ Hereditary optic atrophy (Leber’s disease).PearsonK, ed. The treasury of human inheritance Cambridge: Cambridge University Press, 1931:345–423 </plain></SENT>
</text></ref><ref id="b5"><text><SENT sid="2354" pm="."><plain>5ImaiYMoriwakiD A probable case of cytoplasmic inheritance in man: a critique of Leber’s disease.J Genet1936;33:163–7 </plain></SENT>
</text></ref><ref id="b6"><text><SENT sid="2355" pm="."><plain>6LundsgaardR A genealogic, genetic and clinical study of 101 cases of retrobulbar optic neuritis in 20 Danish families.Acta Ophthalmol1944;21:1–306 </plain></SENT>
</text></ref><ref id="b7"><text><SENT sid="2356" pm="."><plain>7WallaceDCSinghGLottMTHodgeJASchurrTGLezzaAMElsasLJdNikoskelainenEK Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy.Science1988;242:1427–303201231 </plain></SENT>
</text></ref><ref id="b8"><text><SENT sid="2357" pm="."><plain>8MackeyDAOostraRJRosenbergTNikoskelainenEBronte-StewartJPoultonJHardingAEGovanGBolhuisPANorbyS Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy.Am J Hum Genet1996;59:481–58755941 </plain></SENT>
</text></ref><ref id="b9"><text><SENT sid="2358" pm="."><plain>9MashimaYYamadaKWakakuraMKigasawaKKudohJShimizuNOguchiY Spectrum of pathogenic mitochondrial DNA mutations and clinical features in Japanese families with Leber’s hereditary optic neuropathy.Curr Eye Res1998;17:403–89561832 </plain></SENT>
</text></ref><ref id="b10"><text><SENT sid="2359" pm="."><plain>10YenMYWangAGChangWLHsuWMLiuJHWeiYH Leber’s hereditary optic neuropathy-the spectrum of mitochondrial DNA mutations in Chinese patients.Jpn J Ophthalmol2002;46:45–5111853713 </plain></SENT>
</text></ref><ref id="b11"><text><SENT sid="2360" pm="."><plain>11MacmillanCKirkhamTFuKAllisonVAndermannEChitayatDFortierDGansMHareHQuerciaNZackonDShoubridgeEA Pedigree analysis of French Canadian families with T14484C Leber’s hereditary optic neuropathy.Neurology1998;50:417–229484365 </plain></SENT>
</text></ref><ref id="b12"><text><SENT sid="2361" pm="."><plain>12MacmillanCJohnsTAFuKShoubridgeEA Predominance of the T14484C mutation in French-Canadian families with Leber hereditary optic neuropathy is due to a founder effect [letter].Am J Hum Genet2000;66:332–510631164 </plain></SENT>
</text></ref><ref id="b13"><text><SENT sid="2362" pm="."><plain>13TaylorRWJoblingMSTurnbullDMChinneryPF Frequency of rare mitochondrial DNA mutations in patients with suspected Leber’s hereditary optic neuropathy.J Med Genet2003;40:e8512843334 </plain></SENT>
</text></ref><ref id="b14"><text><SENT sid="2363" pm="."><plain>14ManPYGriffithsPGBrownDTHowellNTurnbullDMChinneryPF The epidemiology of Leber hereditary optic neuropathy in the North East of England.Am J Hum Genet2003;72:333–912518276 </plain></SENT>
</text></ref><ref id="b15"><text><SENT sid="2364" pm="."><plain>15SpruijtLKolbachDNde CooRFPlompASBauerNJSmeetsHJde Die-SmuldersCEM Influence of mutation type on clinical expression of Leber hereditary optic neuropathy.Am J Ophthalmol2006;141:676–8216564802 </plain></SENT>
</text></ref><ref id="b16"><text><SENT sid="2365" pm="."><plain>16PuomilaAHamalainenPKiviojaSSavontausMLKoivumakiSHuoponenKNikoskelainenE Epidemiology and penetrance of Leber hereditary optic neuropathy in Finland.Eur J Hum Genet2007;15:1079–8917406640 </plain></SENT>
</text></ref><ref id="b17"><text><SENT sid="2366" pm="."><plain>17MackeyDAButteryRG Leber hereditary optic neuropathy in Australia.Aust N Z J Ophthalmol1992;20:177–841449769 </plain></SENT>
</text></ref><ref id="b18"><text><SENT sid="2367" pm="."><plain>18Yu-Wai-ManPBatemanDEHudsonGGriffithsPGChinneryPF Leber hereditary optic neuropathy presenting in a 75-year-old man.J Neuroophthalmol2008;28:15518562849 </plain></SENT>
</text></ref><ref id="b19"><text><SENT sid="2368" pm="."><plain>19DagiLRRizzoJF3rdCestariDM Leber hereditary optic neuropathy in an octogenarian.J Neuroophthalmol2008;28:15618562851 </plain></SENT>
</text></ref><ref id="b20"><text><SENT sid="2369" pm="."><plain>20HardingAESweeneyMGGovanGGRiordan-EvaP Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation.Am J Hum Genet1995;57:77–867611298 </plain></SENT>
</text></ref><ref id="b21"><text><SENT sid="2370" pm="."><plain>21NewmanNJLottMTWallaceDC The clinical characteristics of pedigrees of Leber’s hereditary optic neuropathy with the 11778 mutation.Am J Ophthalmol1991;111:750–622039048 </plain></SENT>
</text></ref><ref id="b22"><text><SENT sid="2371" pm="."><plain>22JohnsDRSmithKHMillerNR Leber’s hereditary optic neuropathy. </plain></SENT>
<SENT sid="2372" pm="."><plain>Clinical manifestations of the 3460 mutation.Arch Ophthalmol1992;110:1577–811444915 </plain></SENT>
</text></ref><ref id="b23"><text><SENT sid="2373" pm="."><plain>23JohnsDRHeherKLMillerNRSmithKH Leber’s hereditary optic neuropathy. </plain></SENT>
<SENT sid="2374" pm="."><plain>Clinical manifestations of the 14484 mutation.Arch Ophthalmol1993;111:495–88470982 </plain></SENT>
</text></ref><ref id="b24"><text><SENT sid="2375" pm="."><plain>24BiousseVBrownMDNewmanNJAllenJCRosenfeldJMeolaGWallaceDC De novo 14484 mitochondrial DNA mutation in monozygotic twins discordant for Leber’s hereditary optic neuropathy.Neurology1997;49:1136–89339703 </plain></SENT>
</text></ref><ref id="b25"><text><SENT sid="2376" pm="."><plain>25SaviniGBarboniPValentinoMLMontagnaPCortelliPDe NegriAMSadunFBianchiSLonganesiLZaniniMCarelliV Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber’s hereditary optic neuropathy mutations.Ophthalmology2005;112:127–3115629832 </plain></SENT>
</text></ref><ref id="b26"><text><SENT sid="2377" pm="."><plain>26QuirosPATorresRJSalomaoSBerezovskyACarelliVShermanJSadunFDe NegriABelfortRSadunAA Colour vision defects in asymptomatic carriers of the Leber’s hereditary optic neuropathy (LHON) mtDNA 11778 mutation from a large Brazilian LHON pedigree: a case-control study.Br J Ophthalmol2006;90:150–316424523 </plain></SENT>
</text></ref><ref id="b27"><text><SENT sid="2378" pm="."><plain>27SadunAASalomaoSRBerezovskyASadunFDenegriAMQuirosPAChicaniFVenturaDBarboniPShermanJSutterEBelfortRJrCarelliVPatsiJKervinenMFinelMHassinenIE Subclinical carriers and conversions in Leber hereditary optic neuropathy: a prospective psychophysical study.Trans Am Ophthalmol Soc2006;104:51–6117471325 </plain></SENT>
</text></ref><ref id="b28"><text><SENT sid="2379" pm="."><plain>28NikoskelainenEKHuoponenKJuvonenVLamminenTNummelinKSavontausML Ophthalmologic findings in Leber hereditary optic neuropathy, with special reference to mtDNA mutations.Ophthalmology1996;103:504–148600429 </plain></SENT>
</text></ref><ref id="b29"><text><SENT sid="2380" pm="."><plain>29SugisakaEOhdeHShinodaKMashimaY Woman with atypical unilateral Leber’s hereditary optic neuropathy with visual improvement.Clin Exp Ophthalmol2007;35:868–70 </plain></SENT>
</text></ref><ref id="b30"><text><SENT sid="2381" pm="."><plain>30NikoskelainenEK Clinical picture of LHON.Clin Neurosci1994;2:115–20 </plain></SENT>
</text></ref><ref id="b31"><text><SENT sid="2382" pm="."><plain>31Riordan-EvaPHardingAE Leber’s hereditary optic neuropathy: the clinical relevance of different mitochondrial DNA mutations.J Med Genet1995;32:81–77760326 </plain></SENT>
</text></ref><ref id="b32"><text><SENT sid="2383" pm="."><plain>32MackeyDHowellN A variant of Leber hereditary optic neuropathy characterized by recovery of vision and by an unusual mitochondrial genetic etiology.Am J Hum Genet1992;51:1218–281463007 </plain></SENT>
</text></ref><ref id="b33"><text><SENT sid="2384" pm="."><plain>33StoneEMNewmanNJMillerNRJohnsDRLottMTWallaceDC Visual recovery in patients with Leber’s hereditary optic neuropathy and the 11778 mutation.J Clin Neuroophthalmol1992;12:10–41532593 </plain></SENT>
</text></ref><ref id="b34"><text><SENT sid="2385" pm="."><plain>34BarboniPSaviniGValentinoMLLa MorgiaCBellusciCDe NegriAMSadunFCartaACarbonelliMSadunAACarelliV Leber’s hereditary optic neuropathy with childhood onset.Invest Ophthalmol Vis Sci2006;47:5303–917122117 </plain></SENT>
</text></ref><ref id="b35"><text><SENT sid="2386" pm="."><plain>35BowerSPHawleyIMackeyDA Cardiac arrhythmia and Leber’s hereditary optic neuropathy [letter].Lancet1992;339:1427–81350847 </plain></SENT>
</text></ref><ref id="b36"><text><SENT sid="2387" pm="."><plain>36NikoskelainenEKSavontausMLHuoponenKAntilaKHartialaJ Pre-excitation syndrome in Leber’s hereditary optic neuropathy.Lancet1994;344:857–87916404 </plain></SENT>
</text></ref><ref id="b37"><text><SENT sid="2388" pm="."><plain>37NikoskelainenEKMarttilaRJHuoponenKJuvonenVLamminenTSonninenPSavontausML Leber’s “plus”: neurological abnormalities in patients with Leber’s hereditary optic neuropathy.J Neurol Neurosurg Psychiatry1995;59:160–47629530 </plain></SENT>
</text></ref><ref id="b38"><text><SENT sid="2389" pm="."><plain>38MeireFMVan CosterRCochauxPObermaier-KusserBCandaeleCMartinJJ Neurological disorders in members of families with Leber’s hereditary optic neuropathy (LHON) caused by different mitochondrial mutations.Ophthalm Genet1995;16:119–26 </plain></SENT>
</text></ref><ref id="b39"><text><SENT sid="2390" pm="."><plain>39MashimaYKigasawaKHasegawaHTaniMOguchiY High incidence of pre-excitation syndrome in Japanese families with Leber’s hereditary optic neuropathy.Clin Genet1996;50:535–79147893 </plain></SENT>
</text></ref><ref id="b40"><text><SENT sid="2391" pm="."><plain>40De VriesDDWentLNBruynGWScholteHRHofstraRMBolhuisPAvan OostBA Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia.Am J Hum Genet1996;58:703–118644732 </plain></SENT>
</text></ref><ref id="b41"><text><SENT sid="2392" pm="."><plain>41HowellNKubackaIXuMMcCulloughDA Leber hereditary optic neuropathy: involvement of the mitochondrial ND1 gene and evidence for an intragenic suppressor mutation.Am J Hum Genet1991;48:935–422018041 </plain></SENT>
</text></ref><ref id="b42"><text><SENT sid="2393" pm="."><plain>42JunASBrownMDWallaceDC A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia.Proc Natl Acad Sci USA1994;91:6206–108016139 </plain></SENT>
</text></ref><ref id="b43"><text><SENT sid="2394" pm="."><plain>43GropmanAChenTJPerngCLKrasnewichDChernoffETifftCWongLJ Variable clinical manifestation of homoplasmic G14459A mitochondrial DNA mutation.Am J Med Genet Part A2004;124:377–82 </plain></SENT>
</text></ref><ref id="b44"><text><SENT sid="2395" pm="."><plain>44TarnopolskyMABakerSKMyintTMaxnerCERobitailleJRobinsonBH Clinical variability in maternally inherited Leber hereditary optic neuropathy with the G14459A mutation.Am J Med Genet Part A2004;124:372–6 </plain></SENT>
</text></ref><ref id="b45"><text><SENT sid="2396" pm="."><plain>45BlakelyELde SilvaRKingASchwarzerVHarrowerTDawidekGTurnbullDMTaylorRW LHON/MELAS overlap syndrome associated with a mitochondrial MTND1 gene mutation.Eur J Hum Genet2005;13:623–715657614 </plain></SENT>
</text></ref><ref id="b46"><text><SENT sid="2397" pm="."><plain>46SpruijtLSmeetsHJHendrickxABettink-RemeijerMWMaat-KievitASchoonderwoerdKCSluiterWde CooIFHintzenRQ A MELAS-associated ND1 mutation causing Leber hereditary optic neuropathy and spastic dystonia.Arch Neurol2007;64:890–317562939 </plain></SENT>
</text></ref><ref id="b47"><text><SENT sid="2398" pm="."><plain>47HardingAESweeneyMGMillerDHMumfordCJKellar-WoodHMenardDMcDonaldWICompstonDA Occurrence of a multiple sclerosis-like illness in women who have a Leber’s hereditary optic neuropathy mitochondrial DNA mutation.Brain1992;115:979–891393514 </plain></SENT>
</text></ref><ref id="b48"><text><SENT sid="2399" pm="."><plain>48Kellar-WoodHRobertsonNGovanGGCompstonDAHardingAE Leber’s hereditary optic neuropathy mitochondrial DNA mutations in multiple sclerosis.Ann Neurol1994;36:109–128024249 </plain></SENT>
</text></ref><ref id="b49"><text><SENT sid="2400" pm="."><plain>49JansenPHvan der KnaapMSde CooIF Leber’s hereditary optic neuropathy with the 11 778 mtDNA mutation and white matter disease resembling multiple sclerosis: clinical, MRI and MRS findings.J Neurol Sci1996;135:176–808867076 </plain></SENT>
</text></ref><ref id="b50"><text><SENT sid="2401" pm="."><plain>50VanopdenboschLDuboisBD’HoogheMBMeireFCartonH Mitochondrial mutations of Leber’s hereditary optic neuropathy: a risk factor for multiple sclerosis.J Neurol2000;247:535–4310993496 </plain></SENT>
</text></ref><ref id="b51"><text><SENT sid="2402" pm="."><plain>51GovanGGSmithPRKellar-WoodHSchapiraAHHardingAE HLA class II genotypes in Leber’s hereditary optic neuropathy.J Neurol Sci1994;126:193–67853025 </plain></SENT>
</text></ref><ref id="b52"><text><SENT sid="2403" pm="."><plain>52SmithPRCooperJMGovanGGRiordan-EvaPHardingAESchapiraAH Antibodies to human optic nerve in Leber’s hereditary optic neuropathy.J Neurol Sci1995;130:134–88586976 </plain></SENT>
</text></ref><ref id="b53"><text><SENT sid="2404" pm="."><plain>53ChalmersRMGovanGGSchapiraAHHardingAE HLA class I genotypes in Leber’s hereditary optic neuropathy.J Neurol Sci1996;135:173–58867075 </plain></SENT>
</text></ref><ref id="b54"><text><SENT sid="2405" pm="."><plain>54SapeyEBurdonMANightingaleS Evidence of active demyelination in a man with Leber’s hereditary optic neuropathy mtDNA 14484 genotype.Neuro-Ophthalmology2001;26:119–26 </plain></SENT>
</text></ref><ref id="b55"><text><SENT sid="2406" pm="."><plain>55KovacsGGHoftbergerRMajtenyiKHorvathRBarsiPKomolySLassmannHBudkaHJakabG Neuropathology of white matter disease in Leber’s hereditary optic neuropathy.Brain2005;128:35–4115483043 </plain></SENT>
</text></ref><ref id="b56"><text><SENT sid="2407" pm="."><plain>56ShermanJKleinerL Visual-system dysfunction in Lebers hereditary optic neuropathy.Clin Neurosci1994;2:121–9 </plain></SENT>
</text></ref><ref id="b57"><text><SENT sid="2408" pm="."><plain>57SmithJLTseDTByrneSFJohnsDRStoneEM Optic nerve sheath distention in Leber’s optic neuropathy and the significance of the “Wallace mutation”.J Clin Neuroophthalmol1990;10:231–82150839 </plain></SENT>
</text></ref><ref id="b58"><text><SENT sid="2409" pm="."><plain>58de GottrauPBuchiERDaickerB Distended optic nerve sheaths in Leber’s hereditary optic neuropathy.J Clin Neuroophthalmol1992;12:89–931629376 </plain></SENT>
</text></ref><ref id="b59"><text><SENT sid="2410" pm="."><plain>59DottiMTCaputoNSignoriniEFedericoA Magnetic resonance imaging findings in Leber’s hereditary optic neuropathy.Eur Neurol1992;32:17–91563448 </plain></SENT>
</text></ref><ref id="b60"><text><SENT sid="2411" pm="."><plain>60MashimaYOshitariKImamuraYMomoshimaSShigaHOguchiY Orbital high resolution magnetic resonance imaging with fast spin echo in the acute stage of Leber’s hereditary optic neuropathy.J Neurol Neurosurg Psychiatry1998;64:124–79436742 </plain></SENT>
</text></ref><ref id="b61"><text><SENT sid="2412" pm="."><plain>61VaphiadesMSNewmanNJ Optic nerve enhancement on orbital magnetic resonance imaging in Leber’s hereditary optic neuropathy.J Neuroophthalmol1999;19:238–910608675 </plain></SENT>
</text></ref><ref id="b62"><text><SENT sid="2413" pm="."><plain>62IngleseMRovarisMBianchiSMancardiGLGhezziASalviFCortelliPFilippiM MRI, MTI, and DWI study of the optic nerve, brain, and cervical cord from patients with Leber hereditary optic neuropathy.Neurology2000;54:A320–A </plain></SENT>
</text></ref><ref id="b63"><text><SENT sid="2414" pm="."><plain>63BarbiroliBMontagnaPCortelliPIottiSLodiRBarboniPMonariLLugaresiEFrassinetiCZaniolP Defective brain and muscle energy metabolism shown by in vivo 31P magnetic resonance spectroscopy in nonaffected carriers of 11778 mtDNA mutation.Neurology1995;45:1364–97617199 </plain></SENT>
</text></ref><ref id="b64"><text><SENT sid="2415" pm="."><plain>64CortelliPMontagnaPPierangeliGLodiRBarboniPLiguoriRCarelliVIottiSZaniolPLugaresiEBarbiroliB Clinical and brain bioenergetics improvement with idebenone in a patient with Leber’s hereditary optic neuropathy: a clinical and 31P-MRS study.J Neurol Sci1997;148:25–319125387 </plain></SENT>
</text></ref><ref id="b65"><text><SENT sid="2416" pm="."><plain>65LodiRTaylorDJTabriziSJKumarSSweeneyMWoodNWStylesPRaddaGKSchapiraAHV In vivo skeletal muscle mitochondrial function in Leber’s hereditary optic neuropathy assessed by P-31 magnetic resonance spectroscopy.Ann Neurol1997;42:573–99382468 </plain></SENT>
</text></ref><ref id="b66"><text><SENT sid="2417" pm="."><plain>66LodiRMontagnaPCortelliPIottiSCevoliSCarelliVBarbiroliB ‘Secondary’ 4216/ND1 and 13708/ND5 Leber’s hereditary optic neuropathy mitochondrial DNA mutations do not further impair in vivo mitochondrial oxidative metabolism when associated with the 11778/ND4 mitochondrial DNA mutation.Brain2000;123:1896–90210960053 </plain></SENT>
</text></ref><ref id="b67"><text><SENT sid="2418" pm="."><plain>67LodiRCarelliVCortelliPIottiSValentinoMLBarboniPPallottiFMontagnaPBarbiroliB Phosphorus MR spectroscopy shows a tissue specific in vivo distribution of biochemical expression of the G3460A mutation in Leber’s hereditary optic neuropathy.J Neuro Neurosurg Psychiatry2002;72:805–7 </plain></SENT>
</text></ref><ref id="b68"><text><SENT sid="2419" pm="."><plain>68BerettaSMattavelliLSalaGTremolizzoLSchapiraAHMartinuzziACarelliVFerrareseC Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines.Brain2004;127:2183–9215342361 </plain></SENT>
</text></ref><ref id="b69"><text><SENT sid="2420" pm="."><plain>69BerettaSWoodJPMDerhamBSalaGTremolizzoLFerrareseCOsborneNN Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. </plain></SENT>
<SENT sid="2421" pm="."><plain>Relevance to Leber hereditary optic neuropathy (LHON).Neurobiol Dis2006;24:308–1716959493 </plain></SENT>
</text></ref><ref id="b70"><text><SENT sid="2422" pm="."><plain>70FloreaniMNapoliEMartinuzziAPantanoGDe RivaVTrevisanRBisettoEValenteLCarelliVDabbeni-SalaF Antioxidant defences in cybrids harboring mtDNA mutations associated with Leber’s hereditary optic neuropathy.Febs J2005;272:1124–3515720387 </plain></SENT>
</text></ref><ref id="b71"><text><SENT sid="2423" pm="."><plain>71CarelliVRugoloMSgarbiGGhelliAZannaCBaraccaALenazGNapoliEMartinuzziASolainiG Bioenergetics shapes cellular death pathways in Leber’s hereditary optic neuropathy: a model of mitochondrial neurodegeneration.Biochim Biophys Acta Bioenerg2004;1658:172–9 </plain></SENT>
</text></ref><ref id="b72"><text><SENT sid="2424" pm="."><plain>72DanielsonSRWongACarelliVMartinuzziASchapiraAHCortopassiGA Cells bearing mutations causing Leber’s hereditary optic neuropathy are sensitized to Fas-induced apoptosis.J Biol Chem2002;277:5810–511741983 </plain></SENT>
</text></ref><ref id="b73"><text><SENT sid="2425" pm="."><plain>73ZannaCGhelliAPorcelliAMMartinuzziACarelliVRugoloM Caspase-independent death of Leber’s hereditary optic neuropathy cybrids is driven by energetic failure and mediated by AIF and endonuclease G.Apoptosis2005;10:997–100716151635 </plain></SENT>
</text></ref><ref id="b74"><text><SENT sid="2426" pm="."><plain>74KlivenyiPKargERozsaCHorvathRKomolySNemethITuriSVecseiL alpha-Tocopherol/lipid ratio in blood is decreased in patients with Leber’s hereditary optic neuropathy and asymptomatic carriers of the 11778 mtDNA mutation.J Neurol Neurosurg Psychiatry2001;70:359–6211181859 </plain></SENT>
</text></ref><ref id="b75"><text><SENT sid="2427" pm="."><plain>75YenMYKaoSHWangAGWeiYH Increased 8-hydroxy-2’-deoxyguanosine in leukocyte DNA in Leber’s hereditary optic neuropathy.Invest Ophthalmol Vis Sci2004;45:1688–9115161827 </plain></SENT>
</text></ref><ref id="b76"><text><SENT sid="2428" pm="."><plain>76ZhangXJonesDGonzalez-LimaF Mouse model of optic neuropathy caused by mitochondrial complex I dysfunction.Neurosci Lett2002;326:97–10012057837 </plain></SENT>
</text></ref><ref id="b77"><text><SENT sid="2429" pm="."><plain>77QiXPLewinASHauswirthWWGuyJ Suppression of complex I gene expression induces optic neuropathy.Ann Neurol2003;53:198–20512557286 </plain></SENT>
</text></ref><ref id="b78"><text><SENT sid="2430" pm="."><plain>78QiXPSunLLewinASHauswirthWWGuyJ The mutant human ND4 subunit of complex I induces optic neuropathy in the mouse.Invest Ophthalmol Vis Sci2007;48:1–1017197509 </plain></SENT>
</text></ref><ref id="b79"><text><SENT sid="2431" pm="."><plain>79SmithKHJohnsDRHeherKLMillerNR Heteroplasmy in Leber’s hereditary optic neuropathy.Arch Ophthalmol1993;111:1486–908240102 </plain></SENT>
</text></ref><ref id="b80"><text><SENT sid="2432" pm="."><plain>80ChinneryPFAndrewsRMTurnbullDMHowellNN Leber hereditary optic neuropathy: does heteroplasmy influence the inheritance and expression of the G11778A mitochondrial DNA mutation?Am J Med Genet2001;98:235–4311169561 </plain></SENT>
</text></ref><ref id="b81"><text><SENT sid="2433" pm="."><plain>81BrownWMGeorgeMJrWilsonAC Rapid evolution of animal mitochondrial DNA.Proc Natl Acad Sci USA1979;76:1967–71109836 </plain></SENT>
</text></ref><ref id="b82"><text><SENT sid="2434" pm="."><plain>82WallaceDCBrownMDLottMT Mitochondrial DNA variation in human evolution and disease.Gene1999;238:211–3010570998 </plain></SENT>
</text></ref><ref id="b83"><text><SENT sid="2435" pm="."><plain>83TorroniAHuoponenKFrancalacciPPetrozziMMorelliLScozzariRObinuDSavontausMLWallaceDC Classification of European mtDNAs from an analysis of three European populations.Genetics1996;144:1835–508978068 </plain></SENT>
</text></ref><ref id="b84"><text><SENT sid="2436" pm="."><plain>84HofmannSJakschMBezoldRMertensSAholtSPaprottaAGerbitzKD Population genetics and disease susceptibility: characterization of central European haplogroups by mtDNA gene mutations, correlation with D loop variants and association with disease.Hum Mol Genet1997;6:1835–469302261 </plain></SENT>
</text></ref><ref id="b85"><text><SENT sid="2437" pm="."><plain>85HudsonGCarelliVSpruijtLGerardsMMowbrayCAchilliAPyleAElsonJHowellNLa MorgiaCValentinoMLHuoponenKSavontausMLNikoskelainenESadunAASalomaoSRBelfortRGriffithsPManPYWde CooRFMHorvathRZevianiMSmeetsHJTTorroniAChinneryPF Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background.Am J Hum Genet2007;81:228–3317668373 </plain></SENT>
</text></ref><ref id="b86"><text><SENT sid="2438" pm="."><plain>86DudkinaNVEubelHKeegstraWBoekemaEJBraunHP Structure of a mitochondrial supercomplex formed by respiratory-chain complexes I and III.Proc Natl Acad Sci USA2005;102:3225–915713802 </plain></SENT>
</text></ref><ref id="b87"><text><SENT sid="2439" pm="."><plain>87CarelliVAchilliAValentinoMLRengoCSeminoOPalaMOlivieriAMattiazziMPallottiFCarraraFZevianiMLeuzziVCarducciCValleGSimionatiBMendietaLSalomaoSBelfortRJrSadunAATorroniA Haplogroup effects and recombination of mitochondrial DNA: novel clues from the analysis of Leber hereditary optic neuropathy pedigrees.Am J Hum Genet2006;78:564–7416532388 </plain></SENT>
</text></ref><ref id="b88"><text><SENT sid="2440" pm="."><plain>88VerganiLMartinuzziACarelliVCortelliPMontagnaPSchievanoGCarrozzoRAngeliniCLugaresiE MtDNA mutations associated with Leber’s hereditary optic neuropathy: studies on cytoplasmic hybrid (cybrid) cells.Biochem Biophys Res Commun1995;210:880–87763260 </plain></SENT>
</text></ref><ref id="b89"><text><SENT sid="2441" pm="."><plain>89TharaphanPChuenkongkaewWLLuangtrakoolKSanpachudayanTSuktitipatBSuphavilaiRSrisawatCSuraTLertritP Mitochondrial DNA haplogroup distribution in pedigrees of Southeast Asian G11778A Leber hereditary optic neuropathy.J Neuroophthalmol2006;26:264–717204919 </plain></SENT>
</text></ref><ref id="b90"><text><SENT sid="2442" pm="."><plain>90BuXDRotterJI X chromosome-linked and mitochondrial gene control of Leber hereditary optic neuropathy: evidence from segregation analysis for dependence on X chromosome inactivation.Proc Natl Acad Sci USA1991;88:8198–2021896469 </plain></SENT>
</text></ref><ref id="b91"><text><SENT sid="2443" pm="."><plain>91BuXRotterJI Leber hereditary optic neuropathy: estimation of number of embryonic precursor cells and disease threshold in heterozygous affected females at the X-linked locus.Clin Genet1992;42:143–81395084 </plain></SENT>
</text></ref><ref id="b92"><text><SENT sid="2444" pm="."><plain>92NakamuraMFujiwaraYYamamotoM The two locus control of Leber hereditary optic neuropathy and a high penetrance in Japanese pedigrees.Hum Genet1993;91:339–418500789 </plain></SENT>
</text></ref><ref id="b93"><text><SENT sid="2445" pm="."><plain>93PegoraroECarelliVZevianiMCortelliPMontagnaPBarboniPAngeliniCHoffmanEP X-inactivation patterns in female Leber’s hereditary optic neuropathy patients do not support a strong X-linked determinant.Am J Med Genet1996;61:356–628834048 </plain></SENT>
</text></ref><ref id="b94"><text><SENT sid="2446" pm="."><plain>94OostraRJKempSBolhuisPABleeker-WagemakersEM No evidence for ‘skewed’ inactivation of the X-chromosome as cause of Leber’s hereditary optic neuropathy in female carriers.Hum Genet1996;97:500–58834251 </plain></SENT>
</text></ref><ref id="b95"><text><SENT sid="2447" pm="."><plain>95HudsonGCarelliVHorvathRZevianiMSmeetsHJChinneryPF X-Inactivation patterns in females harboring mtDNA mutations that cause Leber hereditary optic neuropathy.Mol Vis2007;13:2339–4318199976 </plain></SENT>
</text></ref><ref id="b96"><text><SENT sid="2448" pm="."><plain>96ChenJDCoxIDentonMJ Preliminary exclusion of an X-linked gene in Leber optic atrophy by linkage analysis.Hum Genet1989;82:203–72731932 </plain></SENT>
</text></ref><ref id="b97"><text><SENT sid="2449" pm="."><plain>97CarvalhoMRMullerBRotzerEBerningerTKommerellGBlankenagelASavontausMLMeitingerTLorenzB Leber’s hereditary optic neuroretinopathy and the X-chromosomal susceptibility factor: no linkage to DXs7.Hum Hered1992;42(5):316–201360941 </plain></SENT>
</text></ref><ref id="b98"><text><SENT sid="2450" pm="."><plain>98SweeneyMGDavisMBLashwoodABrockingtonMToscanoAHardingAE Evidence against an X-linked locus close to DXS7 determining visual loss susceptibility in British and Italian families with Leber hereditary optic neuropathy.Am J Hum Genet1992;51:741–81415219 </plain></SENT>
</text></ref><ref id="b99"><text><SENT sid="2451" pm="."><plain>99HandokoHYWirapatiPJSudoyoHASitepuMMarzukiS Meiotic breakpoint mapping of a proposed X linked visual loss susceptibility locus in Leber’s hereditary optic neuropathy.J Med Genet1998;35:668–719719375 </plain></SENT>
</text></ref><ref id="b100"><text><SENT sid="2452" pm="."><plain>100HudsonGKeersSManPYWGriffithsPHuoponenKSavontausMLNikoskelainenEZevianiMCarraraFHorvathRKarcagiVSpruijtLde CooIFMSmeetsHJMChinneryPF Identification of an X-chromosomal locus and haplotype modulating the phenotype of a mitochondrial DNA disorder.Am J Hum Genet2005;77:1086–9116380918 </plain></SENT>
</text></ref><ref id="b101"><text><SENT sid="2453" pm="."><plain>101ShankarSPFingertJHCarelliVValentinoMLKingTMDaigerSPSalomaoSRBerezovskyABelfortR JrBraunTASheffieldVCSadunAAStoneEM Evidence for a novel x-linked modifier locus for Leber hereditary optic neuropathy.Ophthalmic Genet2008;29:17–2418363168 </plain></SENT>
</text></ref><ref id="b102"><text><SENT sid="2454" pm="."><plain>102NikoskelainenEKSavontausMLWanneOPKatilaMJNummelinKU Leber’s hereditary optic neuroretinopathy, a maternally inherited disease. </plain></SENT>
<SENT sid="2455" pm="."><plain>A genealogic study in four pedigrees.Arch Ophthalmol1987;105:665–713619743 </plain></SENT>
</text></ref><ref id="b103"><text><SENT sid="2456" pm="."><plain>103JohnsDRSmithKHMillerNRSulewskiMEBiasWB Identical twins who are discordant for Leber’s hereditary optic neuropathy.Arch Ophthalmol1993;111:1491–48240103 </plain></SENT>
</text></ref><ref id="b104"><text><SENT sid="2457" pm="."><plain>104LamBL Identical twins no longer discordant for Leber’s hereditary optic neuropathy [letter].Arch Ophthalmol1998;116:956–79682718 </plain></SENT>
</text></ref><ref id="b105"><text><SENT sid="2458" pm="."><plain>105Riordan-EvaPSandersMDGovanGGSweeneyMGDa CostaJHardingAE The clinical features of Leber’s hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation.Brain1995;118:319–377735876 </plain></SENT>
</text></ref><ref id="b106"><text><SENT sid="2459" pm="."><plain>106CharlmersRMHardingAE A case-control study of Leber’s hereditary optic neuropathy.Brain1996;119:1481–68931573 </plain></SENT>
</text></ref><ref id="b107"><text><SENT sid="2460" pm="."><plain>107TsaoKAitkenPAJohnsDR Smoking as an aetiological factor in a pedigree with Leber’s hereditary optic neuropathy.Br J Ophthalmol1999;83:577–8110216058 </plain></SENT>
</text></ref><ref id="b108"><text><SENT sid="2461" pm="."><plain>108SadunAACarelliVSalomaoSRBerezovskyAQuirosPASadunFDeNegriAMAndradeRMoraesMPassosAKjaerPPereiraJValentinoMLScheinSBelfortR Extensive investigation of a large Brazilian pedigree of 11778/haplogroup J Leber hereditary optic neuropathy.Am J Ophthalmol2003;136:231–812888043 </plain></SENT>
</text></ref><ref id="b109"><text><SENT sid="2462" pm="."><plain>109KerrisonJBMillerNRHsuFBeatyTHMaumeneeIHSmithKHSavinoPJStoneEMNewmanNJ A case-control study of tobacco and alcohol consumption in Leber hereditary optic neuropathy.Am J Ophthalmol2000;130:803–1211124301 </plain></SENT>
</text></ref><ref id="b110"><text><SENT sid="2463" pm="."><plain>110MackeyDAFingertJHLuzhanskyJZMcCluskeyPJHowellNHallAJHPierceABHoyJF Leber’s hereditary optic neuropathy triggered by antiretroviral therapy for human immunodeficiency virus.Eye2003;17:312–712724691 </plain></SENT>
</text></ref><ref id="b111"><text><SENT sid="2464" pm="."><plain>111SanchezRNSmithAJCarelliVSadunAAKeltnerJL Leber hereditary optic neuropathy possibly triggered by exposure to tire fire.J Neuroophthalmol2006;26:268–7217204920 </plain></SENT>
</text></ref><ref id="b112"><text><SENT sid="2465" pm="."><plain>112CarelliVFranceschiniFVenturiSBarboniPSaviniGBarbieriGPirroELa MorgiaCValentinoMLZanardiFViolanteFSMattioliS Grand rounds: could occupational exposure to n-hexane and other solvents precipitate visual failure in Leber hereditary optic neuropathy?Environ Health Perspect2007;115:113–517366829 </plain></SENT>
</text></ref><ref id="b113"><text><SENT sid="2466" pm="."><plain>113HowellNMackeyDA Low-penetrance branches in matrilineal pedigrees with Leber hereditary optic neuropathy.Am J Hum Genet1998;63:1220–49867707 </plain></SENT>
</text></ref><ref id="b114"><text><SENT sid="2467" pm="."><plain>114SadunFDe NegriAMCarelliVSalomaoSRBerezovskyAAndradeRMoraesMPassosABelfortRDa RosaABQuirosPSadunAA Ophthalmologic findings in a large pedigree of 11778/Haplogroup J Leber hereditary optic neuropathy.Am J Ophthalmol2004;137:271–714962416 </plain></SENT>
</text></ref><ref id="b115"><text><SENT sid="2468" pm="."><plain>115MashimaYKigasawaKWakakuraMOguchiY Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy?J Neuroophthalmol2000;20:166–7011001192 </plain></SENT>
</text></ref><ref id="b116"><text><SENT sid="2469" pm="."><plain>116CarelliVValentinoMLLiguoriRMelettiSVetrugnoRProviniFMancardiGLBandiniFBaruzziAMontagnaP Leber’s hereditary optic neuropathy (LHON/11778) with myoclonus: report of two cases.J Neurol Neurosurg Psychiatry2001;71:813–611723211 </plain></SENT>
</text></ref><ref id="b117"><text><SENT sid="2470" pm="."><plain>117BarnilsNMesaEMunozSFerrer-ArtolaAArrugaJ Response to idebenone and multivitamin therapy in Leber’s hereditary optic neuropathy.Arch Soc Esp Oftalmol2007;82:377–8017573650 </plain></SENT>
</text></ref><ref id="b118"><text><SENT sid="2471" pm="."><plain>118NewmanNJBiousseVDavidRBhattiMTHamiltonSRFarrisBKLesserRLNewmanSATurbinREChenKKeaneyRP Prophylaxis for second eye involvement in Leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical brimonidine purite.Am J Ophthalmol2005;140:407–1516083844 </plain></SENT>
</text></ref><ref id="b119"><text><SENT sid="2472" pm="."><plain>119BattenB A family suffering from hereditary optic atrophy.Transactions of the Ophthalmological Society UK1896;16:125 </plain></SENT>
</text></ref><ref id="b120"><text><SENT sid="2473" pm="."><plain>120KjerB Infantile optic atrophy with dominant transmission.Dan Med Bull1956;3:135–4113356616 </plain></SENT>
</text></ref><ref id="b121"><text><SENT sid="2474" pm="."><plain>121LyleWM Genetic risks. </plain></SENT>
<SENT sid="2475" pm="."><plain>A reference for eye care practitioners Waterloo, Ontario, Canada: University of Waterloo Press, 1990 </plain></SENT>
</text></ref><ref id="b122"><text><SENT sid="2476" pm="."><plain>122ThiseltonDLAlexanderCMorrisABrooksSRosenbergTEibergHKjerBKjerPBhattacharyaSSVotrubaM A frameshift mutation in exon 28 of the OPA1 gene explains the high prevalence of dominant optic atrophy in the Danish population: evidence for a founder effect.Hum Genet2001;109:498–50211735024 </plain></SENT>
</text></ref><ref id="b123"><text><SENT sid="2477" pm="."><plain>123KlineLBGlaserJS Dominant optic atrophy – clinical profile.Arch Ophthalmol1979;97:1680–6314284 </plain></SENT>
</text></ref><ref id="b124"><text><SENT sid="2478" pm="."><plain>124HoytCS Autosomal dominant optic atrophy – a spectrum of disability.Ophthalmology1980;87:245–517422264 </plain></SENT>
</text></ref><ref id="b125"><text><SENT sid="2479" pm="."><plain>125KjerP Infantile optic atrophy with dominant mode of inheritance: a clinical and genetic study of 19 Danish families.Acta Ophthalmol1959;(Suppl 54):1–146 </plain></SENT>
</text></ref><ref id="b126"><text><SENT sid="2480" pm="."><plain>126EliottDTraboulsiEIMaumeneeIH Visual prognosis in autosomal dominant optic atrophy (Kjer type).Am J Ophthalmol1993;115:360–78442497 </plain></SENT>
</text></ref><ref id="b127"><text><SENT sid="2481" pm="."><plain>127VotrubaMMooreATBhattacharyaSS Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy.J Med Genet1998;35:793–8009783700 </plain></SENT>
</text></ref><ref id="b128"><text><SENT sid="2482" pm="."><plain>128PuomilaAHuoponenKMantyjarviMHamalainenPPaananenRSankilaEMSavontausMLSomerMNikoskelainenE Dominant optic atrophy: correlation between clinical and molecular genetic studies.Acta Ophthalmol Scandinavica2005;83:337–46 </plain></SENT>
</text></ref><ref id="b129"><text><SENT sid="2483" pm="."><plain>129CohnACToomesCHewittAWKearnsLSInglehearnCFCraigJEMackeyDA The natural history of OPA1-related autosomal dominant optic atrophy.Br J Ophthalmol2008;24:24 </plain></SENT>
</text></ref><ref id="b130"><text><SENT sid="2484" pm="."><plain>130KjerBEibergHKjerPRosenbergT Dominant optic atrophy mapped to chromosome 3q region. </plain></SENT>
<SENT sid="2485" pm="."><plain>II. </plain></SENT>
<SENT sid="2486" pm="."><plain>Clinical and epidemiological aspects.Acta Ophthalmol Scandinavica1996;74:3–7 </plain></SENT>
</text></ref><ref id="b131"><text><SENT sid="2487" pm="."><plain>131VotrubaMFitzkeFWHolderGECarterABhattacharyaSSMooreAT Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy.Arch Ophthalmol1998;116:351–89514489 </plain></SENT>
</text></ref><ref id="b132"><text><SENT sid="2488" pm="."><plain>132CohnACToomesCPotterCTownsKVHewittAWInglehearnCFCraigJEMackeyDA Autosomal dominant optic atrophy: penetrance and expressivity in patients with OPA1 mutations.Am J Ophthalmol2007;143:656–6217306754 </plain></SENT>
</text></ref><ref id="b133"><text><SENT sid="2489" pm="."><plain>133BerningerTAJaegerWKrastelH Electrophysiology and color perimetry in dominant infantile optic atrophy.Br J Ophthalmol1991;75:49–521991088 </plain></SENT>
</text></ref><ref id="b134"><text><SENT sid="2490" pm="."><plain>134BremnerFDTomlinEAShallo-HoffmannJVotrubaMSmithSE The pupil in dominant optic atrophy.Invest Ophthalmol Vis Sci2001;42:675–811222526 </plain></SENT>
</text></ref><ref id="b135"><text><SENT sid="2491" pm="."><plain>135VotrubaMThiseltonDBhattacharyaSS Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy.Br J Ophthalmol2003;87:48–5312488262 </plain></SENT>
</text></ref><ref id="b136"><text><SENT sid="2492" pm="."><plain>136FournierAVDamjiKFEpsteinDLPollockSC Disc excavation in dominant optic atrophy.Ophthalmology2001;108:1595–60211535456 </plain></SENT>
</text></ref><ref id="b137"><text><SENT sid="2493" pm="."><plain>137ItoYNakamuraMYamakoshiTLinJYatsuyaHTerasakiH Reduction of inner retinal thickness in patients with autosomal dominant optic atrophy associated with OPA1 mutations.Invest Ophthalmol Vis Sci2007;48:4079–8617724190 </plain></SENT>
</text></ref><ref id="b138"><text><SENT sid="2494" pm="."><plain>138KimTWHwangJM Stratus OCT in dominant optic atrophy: features differentiating it from glaucoma.J Glaucoma2007;16:655–818091450 </plain></SENT>
</text></ref><ref id="b139"><text><SENT sid="2495" pm="."><plain>139JohnstonPBGasterRNSmithVCTripathiRC Clinicopathologic study of autosomal dominant optic atrophy.Am J Ophthalmol1979;88:868–75315716 </plain></SENT>
</text></ref><ref id="b140"><text><SENT sid="2496" pm="."><plain>140KjerPJensenOAKlinkenL Histopathology of eye, optic-nerve and brain in a case of dominant optic atrophy.Acta Ophthalmol1983;61:300–126880639 </plain></SENT>
</text></ref><ref id="b141"><text><SENT sid="2497" pm="."><plain>141VotrubaMLearySLosseffNBhattacharyaSSMooreATMillerDHMoseleyIF MRI of the intraorbital optic nerve in patients with autosomal dominant optic atrophy.Neuroradiology2000;42:180–310772138 </plain></SENT>
</text></ref><ref id="b142"><text><SENT sid="2498" pm="."><plain>142DelportoGVingoloEMSteindlKForteRIannacconeARispoliEPannaraleMR Clinical heterogeneity of dominant optic atrophy – the contribution of visual function investigations to diagnosis.Graefes Arch Clin Exp Ophthalmol1994;232:717–277890185 </plain></SENT>
</text></ref><ref id="b143"><text><SENT sid="2499" pm="."><plain>143HolderGEVotrubaMCarterACBhattacharyaSSFitzkeFWMooreAT Electrophysiological findings in dominant optic atrophy (DOA) linking to the OPA1 locus on chromosome 3q 28-qter.Doc Ophthalmol1998;95:217–2810532406 </plain></SENT>
</text></ref><ref id="b144"><text><SENT sid="2500" pm="."><plain>144AlexanderCVotrubaMPeschUEAThiseltonDLMayerSMooreARodriguezMKellnerULeo-KottlerBAuburgerGBhattacharyaSSWissingerB OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28.Nat Genet2000;26:211–511017080 </plain></SENT>
</text></ref><ref id="b145"><text><SENT sid="2501" pm="."><plain>145DelettreCLenaersGGriffoinJMGigarelNLorenzoCBelenguerPPelloquinLGrosgeorgeJTurc-CarelCPerretEAstarie-DequekerCLasquellecLArnaudBDucommunBKaplanJHamelCP Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy.Nat Genet2000;26:207–1011017079 </plain></SENT>
</text></ref><ref id="b146"><text><SENT sid="2502" pm="."><plain>146DaviesVVotrubaM Focus on molecules: the OPA1 protein.Exp Eye Res2006;83:1003–416563384 </plain></SENT>
</text></ref><ref id="b147"><text><SENT sid="2503" pm="."><plain>147NewmanNJBiousseV Hereditary optic neuropathies.Eye2004;18:1144–6015534600 </plain></SENT>
</text></ref><ref id="b148"><text><SENT sid="2504" pm="."><plain>148FuhrmannNAlaviMVWissingerB Genomic rearrangements in the OPA1 gene are frequent in patients with autosomal dominant optic atrophy (poster 5387). The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting.Fort Lauderdale, Florida, 2008 </plain></SENT>
</text></ref><ref id="b149"><text><SENT sid="2505" pm="."><plain>149CosteffHGadothNApterNPrialnicMSavirH A familial syndrome of infantile optic atrophy, movement disorder, and spastic paraplegia.Neurology1989;39:595–72494568 </plain></SENT>
</text></ref><ref id="b150"><text><SENT sid="2506" pm="."><plain>150AniksterYKletaRShaagAGahlWAElpelegO Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews.Am J Hum Genet2001;69:1218–2411668429 </plain></SENT>
</text></ref><ref id="b151"><text><SENT sid="2507" pm="."><plain>151KletaRSkovbyFChristensenERosenbergTGahlWAAniksterY 3-methylglutaconic aciduria type III in a non-Iraqi-Jewish kindred: clinical and molecular findings.Mol Genet Metab2002;76:201–612126933 </plain></SENT>
</text></ref><ref id="b152"><text><SENT sid="2508" pm="."><plain>152ReynierPAmati-BonneauPVernyCOlichonASimardGGuichetABonnemainsCMalecazeFMalingeMCPelletierJBCalvasPDollfusHBelenguerPMalthieryYLenaersGBonneauD OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract.J Med Genet2004;41e110 </plain></SENT>
</text></ref><ref id="b153"><text><SENT sid="2509" pm="."><plain>153VernyCAmati-BonneauPDubasFMalthieryYReynierPBonneauD An OPA3 gene mutation is responsible for the disease associating optic atrophy and cataract with extrapyramidal signs.Revue Neurologique2005;161:451–415924081 </plain></SENT>
</text></ref><ref id="b154"><text><SENT sid="2510" pm="."><plain>154DaviesVJPowellKAWhiteKEYipWHoganVHollinsAJDaviesJRPiechotaMBrownsteinDGMoatSJNicholsPPWrideMABoultonMEVotrubaM A missense mutation in the murine Opa3 gene models human Costeff syndrome.Brain2008;131:368–8018222992 </plain></SENT>
</text></ref><ref id="b155"><text><SENT sid="2511" pm="."><plain>155LeipnitzGSeminottiBAmaralAUde BortoliGSolanoASchuckPFWyseATSWannmacherCMDLatiniAWajnerM Induction of oxidative stress by the metabolites accumulating in 3-methylglutaconic aciduria in cerebral cortex of young rats.Life Sci2008;82:652–6218261750 </plain></SENT>
</text></ref><ref id="b156"><text><SENT sid="2512" pm="."><plain>156OlichonAGuillouEDelettreCLandesTArnaune-PelloquinLEmorineLJMilsVDaloyauMHamelCAmati-BonneauPBonneauDReynierPLenaersGBelenguerP Mitochondrial dynamics and disease, OPA1.Biochim Biophys Acta Mol Cell Res2006;1763:500–9 </plain></SENT>
</text></ref><ref id="b157"><text><SENT sid="2513" pm="."><plain>157FerreMAmati-BonneauPTourmenYMalthieryYReynierP eOPA1: an online database for OPA1 mutations.Hum Mutat2005;25:423–815832306 </plain></SENT>
</text></ref><ref id="b158"><text><SENT sid="2514" pm="."><plain>158PeschUEALeo-KottlerBMayorSJurkliesBKellnerUApfelstedt-SyllaEZrennerEAlexanderCWissingerB OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance.Hum Mol Genet2001;10:1359–6811440988 </plain></SENT>
</text></ref><ref id="b159"><text><SENT sid="2515" pm="."><plain>159SchimpfSSchaichSWissingerB Activation of cryptic splice sites is a frequent splicing defect mechanism caused by mutations in exon and intron sequences of the OPA1 gene.Hum Genet2006;118:767–7116323009 </plain></SENT>
</text></ref><ref id="b160"><text><SENT sid="2516" pm="."><plain>160SchimpfSFuhrmannNSchaichSWissingerB Comprehensive cDNA study and quantitative transcript analysis of mutant OPA1 transcripts containing premature termination codons.Hum Mutat2008;29:106–1217722006 </plain></SENT>
</text></ref><ref id="b161"><text><SENT sid="2517" pm="."><plain>161MarchbankNJCraigJELeekJPTooheyMChurchillAJMarkhamAFMackeyDAToomesCInglehearnCF Deletion of the OPA1 gene in a dominant optic atrophy family: evidence that haploinsufficiency is the cause of disease.J Med Genet2002;39:e4712161614 </plain></SENT>
</text></ref><ref id="b162"><text><SENT sid="2518" pm="."><plain>162Amati-BonneauPValentinoMLReynierPGallardoMEBornsteinBBoissiereACamposYRiveraHde la AlejaJGCarrocciaRIommariniLLabaugePFigarella-BrangerDMarcorellesPFurbyABeauvaisKLetournelFLiguoriRLa MorgiaCMontagnaPLiguoriMZannaCRugoloMCossarizzaAWissingerBVernyCSchwarzenbacherRMartinMAArenasJAyusoCGaresseRLenaersGBonneauDCarelliV OPA1 mutations induce mitochondrial DNA instability and optic atrophy plus phenotypes.Brain2008;131:338–5118158317 </plain></SENT>
</text></ref><ref id="b163"><text><SENT sid="2519" pm="."><plain>163FerrarisSClarkSGarelliEDavidzonGMooreSAKardonRHBienstockRJLongleyMJMancusoMRiosPGHiranoMCopelandWCDiMauroS Progressive external ophthalmoplegia and vision and hearing loss in a patient with mutations in POLG2 and OPA1.Arch Neurol2008;65:125–3118195150 </plain></SENT>
</text></ref><ref id="b164"><text><SENT sid="2520" pm="."><plain>164HudsonGAmati-BonneauPBlakelyELStewartJDHeLPSchaeferAMGriffithsPGAhlqvistKSuomalainenAReynierPMcFarlandRTurnbullDMChinneryPFTaylorRW Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance.Brain2008;131:329–3718065439 </plain></SENT>
</text></ref><ref id="b165"><text><SENT sid="2521" pm="."><plain>165AijazSErskineLJefferyGBhattacharyaSSVotrubaM Developmental expression profile of the optic atrophy gene product: OPA1 is not localized exclusively in the mammalian retinal ganglion cell layer.Invest Ophthalmol Vis Sci2004;45:1667–7315161824 </plain></SENT>
</text></ref><ref id="b166"><text><SENT sid="2522" pm="."><plain>166PeschUEAFriesJEBetteSKalbacherHWissingerBAlexanderCKohlerK OPA1, the disease gene for autosomal dominant optic atrophy, is specifically expressed in ganglion cells and intrinsic neurons of the retina.Invest Ophthalmol Vis Sci2004;45:4217–2515505078 </plain></SENT>
</text></ref><ref id="b167"><text><SENT sid="2523" pm="."><plain>167JuWKMisakaTKushnarevaYNakagomiSAgarwalNKuboYLiptonSABossy-WetzelE OPA1 expression in the normal rat retina and optic nerve.J Comp Neurol2005;488:1–1015912498 </plain></SENT>
</text></ref><ref id="b168"><text><SENT sid="2524" pm="."><plain>168WangAGFannMJYuHYYenMY OPA1 expression in the human retina and optic nerve.Exp Eye Res2006;83:1171–816857190 </plain></SENT>
</text></ref><ref id="b169"><text><SENT sid="2525" pm="."><plain>169BetteSSchlaszusHWissingerBMeyermannRMittelbronnM OPA1, associated with autosomal dominant optic atrophy, is widely expressed in the human brain.Acta Neuropathol2005;109:393–915700187 </plain></SENT>
</text></ref><ref id="b170"><text><SENT sid="2526" pm="."><plain>170KameiSChen-Kuo-ChangMCazevieilleCLenaersGOlichonABelenguerPRoussignolGRenardNEybalinMMichelinADelettreCBrabetPHamelCP Expression of the Opa1 mitochondrial protein in retinal ganglion cells: its downregulation causes aggregation of the mitochondrial network.Invest Ophthalmol Vis Sci2005;46:4288–9416249510 </plain></SENT>
</text></ref><ref id="b171"><text><SENT sid="2527" pm="."><plain>171GuanKLFarhLMarshallTKDeschenesRJ Normal mitochondrial structure and genome maintenance in yeast requires the dynamin-like product of the Mgm1 gene.Curr Genet1993;24:141–87916673 </plain></SENT>
</text></ref><ref id="b172"><text><SENT sid="2528" pm="."><plain>172WongEDWagnerJAScottSVOkreglakVHolewinskeTJCassidy-StoneANunnariJ The intramitochondrial dynamin-related GTPase, Mgm1p, is a component of a protein complex that mediates mitochondrial fusion.J Cell Biol2003;160:303–1112566426 </plain></SENT>
</text></ref><ref id="b173"><text><SENT sid="2529" pm="."><plain>173PraefckeGJKMcMahonHT The dynamin superfamily: universal membrane tubulation and fission molecules?Nat Rev Mol Cell Biol2004;5:133–4715040446 </plain></SENT>
</text></ref><ref id="b174"><text><SENT sid="2530" pm="."><plain>174ChanDC Mitochondrial fusion and fission in mammals.Annu Rev Cell Dev Biol2006;22:79–9916704336 </plain></SENT>
</text></ref><ref id="b175"><text><SENT sid="2531" pm="."><plain>175OlichonALandesTArnaune-PelloquinLEmorineLJMilsVGuichetADelettreCHamelCAmati-BonneauPBonneauDReynierPLenaersGBelenguerP Effects of OPA1 mutations on mitochondrial morphology and apoptosis: relevance to ADOA pathogenesis.J Cell Physiol2007;211:423–3017167772 </plain></SENT>
</text></ref><ref id="b176"><text><SENT sid="2532" pm="."><plain>176ZannaCGhelliAPorcelliAMKarbowskiMYouleRJSchimpfSWissingerBPintiMCossarizzaAVidoniSValentinoMLRugoloMCarelliV OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion.Brain2008;131:352–6718222991 </plain></SENT>
</text></ref><ref id="b177"><text><SENT sid="2533" pm="."><plain>177ChenHChanDC Critical dependence of neurons on mitochondrial dynamics.Curr Opin Cell Biol2006;18:453–916781135 </plain></SENT>
</text></ref><ref id="b178"><text><SENT sid="2534" pm="."><plain>178ChanDC Mitochondrial dynamics in disease.N Engl J Med2007;356:1707–917460225 </plain></SENT>
</text></ref><ref id="b179"><text><SENT sid="2535" pm="."><plain>179ChenHMcCafferyJMChanDC Mitochondrial fusion protects against neurodegeneration in the cerebellum.Cell2007;130:548–6217693261 </plain></SENT>
</text></ref><ref id="b180"><text><SENT sid="2536" pm="."><plain>180KanazawaT The C. elegans Opa1 homologue EAT-3 is essential for resistance to free radicals.PLoS Genet2008;4:e100002218454199 </plain></SENT>
</text></ref><ref id="b181"><text><SENT sid="2537" pm="."><plain>181Amati-BonneauPGuichetAOlichonAChevrollierAVialaFMiotSAyusoCOdentSArrouetCVernyCCalmelsMNSimardGBelenguerPWangJPuelJLHamelCMalthieryYBonneauDLenaersGReynierP OPA1 R445H mutation in optic atrophy associated with sensorineural deafness.Ann Neurol2005;58:958–6316240368 </plain></SENT>
</text></ref><ref id="b182"><text><SENT sid="2538" pm="."><plain>182ChevrollierA Hereditary optic neuropathies share a common mitochondrial coupling defect.Ann Neurol2008;63:794–818496845 </plain></SENT>
</text></ref><ref id="b183"><text><SENT sid="2539" pm="."><plain>183LodiRTononCValentinoMLIottiSClementiVMalucelliEBarboniPLonganesiLSchimpfSWissingerBBaruzziABarbiroliBCarelliV Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy.Ann Neurol2004;56:719–2315505825 </plain></SENT>
</text></ref><ref id="b184"><text><SENT sid="2540" pm="."><plain>184CipolatSRudkaTHartmannDCostaVSerneelsLCraessaertsKMetzgerKFrezzaCAnnaertWD’AdamioLDerksCDejaegereTPellegriniLD’HoogeRScorranoLDe StrooperB Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling.Cell2006;126:163–7516839884 </plain></SENT>
</text></ref><ref id="b185"><text><SENT sid="2541" pm="."><plain>185IshiharaNFujitaYOkaTMiharaK Regulation of mitochondrial morphology through proteolytic cleavage of OPA1.Embo J2006;25:2966–7716778770 </plain></SENT>
</text></ref><ref id="b186"><text><SENT sid="2542" pm="."><plain>186GriparicLKanazawaTvan der BliekAM Regulation of the mitochondrial dynamin-like protein Opa1 by proteolytic cleavage.J Cell Biol2007;178:757–6417709430 </plain></SENT>
</text></ref><ref id="b187"><text><SENT sid="2543" pm="."><plain>187FrezzaCCipolatSde BritoOMMicaroniMBeznoussenkoGVRudkaTBartoliDPolishuckRSDanialNNDe StrooperBScorranoL OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion.Cell2006;126:177–8916839885 </plain></SENT>
</text></ref><ref id="b188"><text><SENT sid="2544" pm="."><plain>188OlichonABaricaultLGasNGuillouEValetteABelenguerPLenaersG Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis.J Biol Chem2003;278:7743–612509422 </plain></SENT>
</text></ref><ref id="b189"><text><SENT sid="2545" pm="."><plain>189AlaviMVBetteSSchimpfSSchuettaufFSchraermeyerUWehrlHFRuttigerLBeckSCTonagelFPichlerBJKnipperMPetersTLaufsJWissingerB A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy.Brain2007;130:1029–4217314202 </plain></SENT>
</text></ref><ref id="b190"><text><SENT sid="2546" pm="."><plain>190DaviesVJHollinsAJPiechotaMJYipWDaviesJRWhiteKENicolsPPBoultonMEVotrubaM Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function.Hum Mol Genet2007;16:1307–1817428816 </plain></SENT>
</text></ref><ref id="b191"><text><SENT sid="2547" pm="."><plain>191Amati-BonneauPOdentSDerrienCPasquierLMalthieryYReynierPBonneauD The association of autosomal dominant optic atrophy and moderate deafness may be due to the R445H mutation in the OPA1 gene.Am J Ophthalmol2003;136:1170–114644237 </plain></SENT>
</text></ref><ref id="b192"><text><SENT sid="2548" pm="."><plain>192LiCMKosmorskyGZhangKKatzBJGeJTraboulsiEI Optic atrophy and sensorineural hearing loss in a family caused by an R445H OPA1 mutation.Am J Med Genet Part A2005;138A:208–11 </plain></SENT>
</text></ref><ref id="b193"><text><SENT sid="2549" pm="."><plain>193LiguoriM A phenotypic variation of dominant optic atrophy and deafness (ADOAD) due to a novel OPA1 mutation.J Neurol2008;255:127–918204809 </plain></SENT>
</text></ref><ref id="b194"><text><SENT sid="2550" pm="."><plain>194VernyC Multiple sclerosis-like disorder in OPA1-related autosomal dominant optic atrophy.Neurology2008;70:1152–318287570 </plain></SENT>
</text></ref><ref id="b195"><text><SENT sid="2551" pm="."><plain>195StewartJDHudsonGYu-Wai-ManPHorvathRMaddisonPWrightABlakelyELHeLPGriffithsPGTurnbullDMTaylorRWChinneryPF OPA1 in multiple mitochondrial DNA deletion disorders.Neurology2008;71:1829–3119029523 </plain></SENT>
</text></ref><ref id="b196"><text><SENT sid="2552" pm="."><plain>196ToomesCMarchbankNJMackeyDACraigJENewbury-EcobRABennettCPVizeCJDesaiSPBlackGCMPatelNTeimoryMMarkhamAFInglehearnCFChurchillAJ Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy.Hum Mol Genet2001;10:1369–7811440989 </plain></SENT>
</text></ref><ref id="b197"><text><SENT sid="2553" pm="."><plain>197ThiseltonDLAlexanderCTaanmanJWBrooksSRosenbergTEibergHAndreassonSVan RegemorterNMunierFLMooreATBhattacharyaSSVotrubaM A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy.Invest Ophthalmol Vis Sci2002;43:1715–2412036970 </plain></SENT>
</text></ref><ref id="b198"><text><SENT sid="2554" pm="."><plain>198CarrollWMKrissABaraitserMBarrettGHallidayAM The incidence and nature of visual pathway involvement in Friedreich’s ataxia. </plain></SENT>
<SENT sid="2555" pm="."><plain>A clinical and visual evoked potential study of 22 patients.Brain1980;103:413–347397485 </plain></SENT>
</text></ref><ref id="b199"><text><SENT sid="2556" pm="."><plain>199LivingstoneIRMastagliaFLEdisRHoweJW Visual involvement in Friedreich’s ataxia and hereditary spastic ataxia. </plain></SENT>
<SENT sid="2557" pm="."><plain>A clinical and visual evoked response study.Arch Neurol1981;38:75–97469840 </plain></SENT>
</text></ref><ref id="b200"><text><SENT sid="2558" pm="."><plain>200ChalmersRMRiordan-EvaPWoodNW Autosomal recessive inheritance of hereditary motor and sensory neuropathy with optic atrophy.J Neurol Neurosurg Psychiatry1997;62:385–79120454 </plain></SENT>
</text></ref><ref id="b201"><text><SENT sid="2559" pm="."><plain>201ZuchnerSDe JonghePJordanovaAClaeysKGGuergueltchevaVCherninkovaSHamiltonSRVan StavernGKrajewskiKMStajichJTournevIVerhoevenKLangerhorstCTde VisserMBaasFBirdTTimmermanVShyMVanceJM Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2.Ann Neurol2006;59:276–8116437557 </plain></SENT>
</text></ref><ref id="b202"><text><SENT sid="2560" pm="."><plain>202LivingstoneIRMastagliaFLEdisRHoweJW Pattern visual evoked responses in hereditary spastic paraplegia.J Neurol Neurosurg Psychiatry1981;44:176–87217977 </plain></SENT>
</text></ref><ref id="b203"><text><SENT sid="2561" pm="."><plain>203MiyamaSArimotoKKimiyaSMiyamaS Complicated hereditary spastic paraplegia with peripheral neuropathy, optic atrophy and mental retardation.Neuropediatrics2000;31:214–711071149 </plain></SENT>
</text></ref><ref id="b204"><text><SENT sid="2562" pm="."><plain>204MakhoulJCordonnierMVan NechelC Optic neuropathy in Strumpell-Lorrain disease: presentation of a clinical case and literature review.Bull Soc Belge Ophtalmol2002;286:9–1412564312 </plain></SENT>
</text></ref><ref id="b205"><text><SENT sid="2563" pm="."><plain>205BunceCWormaldR Leading causes of certification for blindness and partial sight in England &amp; Wales.Bmc Public Health2006;6 </plain></SENT>
</text></ref><ref id="b206"><text><SENT sid="2564" pm="."><plain>206WiggsJL Genetic etiologies of glaucoma.Arch Ophthalmol2007;125:30–717210849 </plain></SENT>
</text></ref><ref id="b207"><text><SENT sid="2565" pm="?"><plain>207BuonoLMForoozanRSergottRCSavinoPJ Is normal tension glaucoma actually an unrecognized hereditary optic neuropathy? </plain></SENT>
<SENT sid="2566" pm="."><plain>New evidence from genetic analysis.Curr Opin Ophthalmol2002;13:362–7012441838 </plain></SENT>
</text></ref><ref id="b208"><text><SENT sid="2567" pm="."><plain>208AungTOcakaLEbenezerNDMorrisAGKrawczakMThiseltonDLAlexanderCVotrubaMBriceGChildAHFrancisPJHitchingsRALehmannOJBhattacharyaSS A major marker for normal tension glaucoma: association with polymorphisms in the OPA1 gene.Hum Genet2002;110:52–611810296 </plain></SENT>
</text></ref><ref id="b209"><text><SENT sid="2568" pm="."><plain>209PowellBToomesCScottSYeungAMarchbankNSpryPLumbRInglehearnCChurchillA Polymorphisms in OPA1 are associated with normal tension glaucoma.Mol Vis2003;9:460–414551537 </plain></SENT>
</text></ref><ref id="b210"><text><SENT sid="2569" pm="."><plain>210MabuchiFTangSKashiwagiKYamagataZIijimaHTsukaharaS The OPA1 gene polymorphism is associated with normal tension and high tension glaucoma.Am J Ophthalmol2007;143:125–3017188046 </plain></SENT>
</text></ref><ref id="b211"><text><SENT sid="2570" pm="."><plain>211Abu-AmeroKKMoralesJBosleyTM Mitochondrial abnormalities in patients with primary open-angle glaucoma.Invest Ophthalmol Vis Sci2006;47:2533–4116723467 </plain></SENT>
</text></ref><ref id="b212"><text><SENT sid="2571" pm="."><plain>212AndrewsRMGriffithsPGJohnsonMATurnbullDM Histochemical localisation of mitochondrial enzyme activity in human optic nerve and retina.Br J Ophthalmol1999;83:231–510396204 </plain></SENT>
</text></ref><ref id="b213"><text><SENT sid="2572" pm="."><plain>213Yu Wai ManCYChinneryPFGriffithsPG Optic neuropathies – importance of spatial distribution of mitochondria as well as function.Med Hypotheses2005;65:1038–4216098682 </plain></SENT>
</text></ref><ref id="b214"><text><SENT sid="2573" pm="."><plain>214BristowEAGriffithsPGAndrewsRMJohnsonMATurnbullDM The distribution of mitochondrial activity in relation to optic nerve structure.Arch Ophthalmol2002;120:791–612049585 </plain></SENT>
</text></ref><ref id="b215"><text><SENT sid="2574" pm="."><plain>215BarronMJGriffithsPTurnbullDMBatesDNicholsP The distributions of mitochondria and sodium channels reflect the specific energy requirements and conduction properties of the human optic nerve head.Br J Ophthalmol2004;88:286–9014736793 </plain></SENT>
</text></ref><ref id="b216"><text><SENT sid="2575" pm="."><plain>216BalohRHSchmidtREPestronkAMilbrandtJ Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations.J Neurosci2007;27:422–3017215403 </plain></SENT>
</text></ref><ref id="b217"><text><SENT sid="2576" pm="."><plain>217DetmerSAVeldeCVClevelandDWChanDC Hindlimb gait defects due to motor axon loss and reduced distal muscles in a transgenic mouse model of Charcot-Marie-Tooth type 2A.Hum Mol Genet2008;17:367–7517959936 </plain></SENT>
</text></ref><ref id="b218"><text><SENT sid="2577" pm="."><plain>218FerreirinhaFQuattriniAPirozziMValsecchiVDinaGBroccoliVAuricchioAPiemonteFTozziGGaetaLCasariGBallabioARugarliEI Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport.J Clin Invest2004;113:231–4214722615 </plain></SENT>
</text></ref><ref id="b219"><text><SENT sid="2578" pm="."><plain>219RugarliEILangerT Translating m-AAA protease function in mitochondria to hereditary spastic paraplegia.Trends Mol Med2006;12:262–916647881 </plain></SENT>
</text></ref><ref id="b220"><text><SENT sid="2579" pm="."><plain>220HuoponenKVilkkiJAulaPNikoskelainenEKSavontausML A new mtDNA mutation associated with Leber hereditary optic neuroretinopathy.Am J Hum Genet1991;48:1147–531674640 </plain></SENT>
</text></ref><ref id="b221"><text><SENT sid="2580" pm="."><plain>221HowellNBindoffLAMcCulloughDAKubackaIPoultonJMackeyDTaylorLTurnbullDM Leber hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees.Am J Hum Genet1991;49:939–501928099 </plain></SENT>
</text></ref><ref id="b222"><text><SENT sid="2581" pm="."><plain>222JohnsDRNeufeldMJParkRD An ND-6 mitochondrial DNA mutation associated with Leber hereditary optic neuropathy.Biochem Biophys Res Commun1992;187:1551–71417830 </plain></SENT>
</text></ref><ref id="b223"><text><SENT sid="2582" pm="."><plain>223ValentinoMLBarboniPGhelliABucchiLRengoCAchilliATorroniALugaresiALodiRBarbiroliBDottiMFedericoABaruzziACarelliV The ND1 gene of complex I is a mutational hot spot for Leber’s hereditary optic neuropathy.Ann Neurol2004;56:631–4115505787 </plain></SENT>
</text></ref><ref id="b224"><text><SENT sid="2583" pm="."><plain>224KimJYHwangJMParkSS Mitochondrial DNA C4171A/ND1 is a novel primary causative mutation of Leber’s hereditary optic neuropathy with a good prognosis.Ann Neurol2002;51:630–412112111 </plain></SENT>
</text></ref><ref id="b225"><text><SENT sid="2584" pm="."><plain>225Leo-KottlerBLuberichsJBeschDChrist-AdlerMFauserS Leber’s hereditary optic neuropathy: clinical and molecular genetic results in a patient with a point mutation at np T11253C (isoleucine to threonine) in the ND4 gene and spontaneous recovery.Graefes Arch Clin Exp Ophthalmol2002;240:758–6412271374 </plain></SENT>
</text></ref><ref id="b226"><text><SENT sid="2585" pm="."><plain>226BrownMDStarikovskayaEDerbenevaOHosseiniSAllenJCMikhailovskayaIESukernikRIWallaceDC The role of mtDNA background in disease expression: a new primary LHON mutation associated with Western Eurasian haplogroup J.Hum Genet2002;110:130–811935318 </plain></SENT>
</text></ref><ref id="b227"><text><SENT sid="2586" pm="."><plain>227MayorovVBiousseVNewmanNJBrownMD The role of the ND5 gene in LHON: characterization of a new, heteroplasmic LHON mutation.Ann Neurol2005;58:807–1116240359 </plain></SENT>
</text></ref><ref id="b228"><text><SENT sid="2587" pm="."><plain>228HowellNHalvorsonSBurnsJMcCulloughDAPaultonJ When does bilateral optic atrophy become Leber hereditary optic neuropathy?Am J Hum Genet1993;53:959–638213825 </plain></SENT>
</text></ref><ref id="b229"><text><SENT sid="2588" pm="."><plain>229BeschDLeo-KottlerBZrennerEWissingerB Leber’s hereditary optic neuropathy: clinical and molecular genetic findings in a patient with a new mutation in the ND6 gene.Graefes Arch Clin Exp Ophthalmol1999;237:745–5210447650 </plain></SENT>
</text></ref><ref id="b230"><text><SENT sid="2589" pm="."><plain>230ZhadanovSIAtamanovVVZhadanovNIOleinikovOVOsipovaLPSchurrTG A novel mtDNA ND6 gene mutation associated with LHON in a Caucasian family.Biochem Biophys Res Commun2005;332:1115–2115922297 </plain></SENT>
</text></ref><ref id="b231"><text><SENT sid="2590" pm="."><plain>231HowellNBogolinCJamiesonRMarendaDRMackeyDA mtDNA mutations that cause optic neuropathy: how do we know?Am J Hum Genet1998;62:196–2029443868 </plain></SENT>
</text></ref><ref id="b232"><text><SENT sid="2591" pm="."><plain>232ChinneryPFBrownDTAndrewsRMSingh-KlerRRiordan-EvaPLindleyJApplegarthDATurnbullDMHowellN The mitochondrial ND6 gene is a hot spot for mutations that cause Leber’s hereditary optic neuropathy.Brain2001;124:209–1811133798 </plain></SENT>
</text></ref><ref id="b233"><text><SENT sid="2592" pm="."><plain>233WissingerBBeschDBaumannBFauserSChrist-AdlerMJurkliesBZrennerELeo-KottlerB Mutation analysis of the ND6 gene in patients with Lebers hereditary optic neuropathy.Biochem Biophys Res Commun1997;234:511–59177303 </plain></SENT>
</text></ref><ref id="b234"><text><SENT sid="2593" pm="."><plain>234FauserSLeo-KottlerBBeschDLuberichsJ Confirmation of the 14568 mutation in the mitochondrial ND6 gene as causative in Leber’s hereditary optic neuropathy.Ophthalmic Genet2002;23:191–712324878 </plain></SENT>
</text></ref><ref id="b235"><text><SENT sid="2594" pm="."><plain>235ParkerWDJrOleyCAParksJK A defect in mitochondrial electron-transport activity (NADH-coenzyme Q oxidoreductase) in Leber’s hereditary optic neuropathy.N Engl J Med1989;320:1331–32497346 </plain></SENT>
</text></ref><ref id="b236"><text><SENT sid="2595" pm="."><plain>236MajanderAHuoponenKSavontausMLNikoskelainenEWikstromM Electron transfer properties of NADH:ubiquinone reductase in the ND1/3460 and the ND4/11778 mutations of the Leber hereditary optic neuroretinopathy (LHON).FEBS Lett1991;292:289–921959619 </plain></SENT>
</text></ref><ref id="b237"><text><SENT sid="2596" pm="."><plain>237LarssonNGAndersenOHolmeEOldforsAWahlstromJ Leber’s hereditary optic neuropathy and complex I deficiency in muscle.Ann Neurol1991;30:701–81763894 </plain></SENT>
</text></ref><ref id="b238"><text><SENT sid="2597" pm="."><plain>238SmithPRCooperJMGovanGGHardingAESchapiraAH Platelet mitochondrial function in Leber’s hereditary optic neuropathy.J Neurol Sci1994;122:80–38195807 </plain></SENT>
</text></ref><ref id="b239"><text><SENT sid="2598" pm="."><plain>239Degli EspostiMCarelliVGhelliARattaMCrimiMSangiorgiSMontagnaPLenazGLugaresiECortelliP Functional alterations of the mitochondrially encoded ND4 subunit associated with Leber’s hereditary optic neuropathy.FEBS Lett1994;352:375–97926004 </plain></SENT>
</text></ref><ref id="b240"><text><SENT sid="2599" pm="."><plain>240CockHRCooperJMSchapiraAH The 14484 ND6 mtDNA mutation in Leber hereditary optic neuropathy does not affect fibroblast complex I activity [letter].Am J Hum Genet1995;57:1501–28533781 </plain></SENT>
</text></ref><ref id="b241"><text><SENT sid="2600" pm="."><plain>241OostraRJVan GalenMJBolhuisPABleeker-WagemakersEMVan den BogertC The mitochondrial DNA mutation ND6*14,484C associated with Leber hereditary optic neuropathy, leads to deficiency of complex I of the respiratory chain.Biochem Biophys Res Commun1995;215:1001–57488023 </plain></SENT>
</text></ref><ref id="b242"><text><SENT sid="2601" pm="."><plain>242MontagnaPPlazziGCortelliPCarelliVLugaresiEBarboniPFiocchiM Abnormal lactate after effort in healthy carriers of Leber’s hereditary optic neuropathy [letter].J Neurol Neurosurg Psychiatry1995;58:640–17745422 </plain></SENT>
</text></ref><ref id="b243"><text><SENT sid="2602" pm="."><plain>243MajanderAFinelMSavontausMLNikoskelainenEWikstromM Catalytic activity of complex I in cell lines that possess replacement mutations in the ND genes in Leber’s hereditary optic neuropathy.Eur J Biochem1996;239:201–78706709 </plain></SENT>
</text></ref><ref id="b244"><text><SENT sid="2603" pm="."><plain>244HofhausGJohnsDRHurkoOAttardiGChomynA Respiration and growth defects in transmitochondrial cell lines carrying the 11778 mutation associated with Leber’s hereditary optic neuropathy.J Biol Chem1996;271:13155–618662757 </plain></SENT>
</text></ref><ref id="b245"><text><SENT sid="2604" pm="."><plain>245CarelliVGhelliARattaMBacchilegaESangiorgiSManciniRLeuzziVCortelliPMontagnaPLugaresiEDegli EspostiM Leber’s hereditary optic neuropathy: biochemical effect of 11778/ND4 and 3460/ND1 mutations and correlation with the mitochondrial genotype.Neurology1997;48:1623–329191778 </plain></SENT>
</text></ref><ref id="b246"><text><SENT sid="2605" pm="."><plain>246CockHRTabriziSJCooperJMSchapiraAH The influence of nuclear background on the biochemical expression of 3460 Leber’s hereditary optic neuropathy.Ann Neurol1998;44:187–939708540 </plain></SENT>
</text></ref><ref id="b247"><text><SENT sid="2606" pm="."><plain>247CockHRCooperJMSchapiraAH Functional consequences of the 3460-bp mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy.J Neurol Sci1999;165:10–710426140 </plain></SENT>
</text></ref><ref id="b248"><text><SENT sid="2607" pm="."><plain>248BrownMDTrounceIAJunASAllenJCWallaceDC Functional analysis of lymphoblast and cybrid mitochondria containing the 3460, 11778, or 14484 Leber’s hereditary optic neuropathy mitochondrial DNA mutation.J Biol Chem2000;275:39831–610976107 </plain></SENT>
</text></ref><ref id="b249"><text><SENT sid="2608" pm="."><plain>249BaraccaASolainiGSgarbiGLenazGBaruzziASchapiraAHMartinuzziACarelliV Severe impairment of complex I-driven adenosine triphosphate synthesis in Leber hereditary optic neuropathy cybrids.Arch Neurol2005;62:730–615883259 </plain></SENT>
</text></ref><ref id="b250"><text><SENT sid="2609" pm="."><plain>250KerrisonJBArnouldVJSallumJMFVagefiMRBarmadaMMLiYYZhuDPMaumeneeIH Genetic heterogeneity of dominant optic atrophy, Kjer type - Identification of a second locus on chromosome 18q12.2–12.3.Arch Ophthalmol1999;117:805–1010369594 </plain></SENT>
</text></ref><ref id="b251"><text><SENT sid="2610" pm="."><plain>251BarbetFHakikiSOrssaudCGerberSPerraultIHaneinSDucroqDDufierJLMunnichAKaplanJRozetJM A third locus for dominant optic atrophy on chromosome 22q.J Med Genet2005;42:e115635063 </plain></SENT>
</text></ref><ref id="b252"><text><SENT sid="2611" pm="."><plain>252CarelliVSchimpfSValentinoMLFuhrmannNPapkeMSchaichSTippmannSBaumannBBarboniPGhelliABucchiLLodiRBarbiroliBLiguoriRCarrocciaRVillanovaMMontagnaPBaruzziAWissingerB Dominant optic atrophy (DOA) and sensorineural hearing loss: clinical, biochemical, spectroscopic and molecular genetic study of a large Italian pedigree linked to a new locus an chromosome 16.Neurology2007;68:A42 </plain></SENT>
</text></ref><ref id="b253"><text><SENT sid="2612" pm="."><plain>253PuccioHKoenigM Friedreich ataxia: a paradigm for mitochondrial diseases.Curr Opin Genet Dev2002;12:272–712076669 </plain></SENT>
</text></ref><ref id="b254"><text><SENT sid="2613" pm="."><plain>254RouaultTATongWH Iron-sulphur cluster biogenesis and mitochondrial iron homeostasis.Nat Rev Mol Cell Biol2005;6:345–5115803140 </plain></SENT>
</text></ref><ref id="b255"><text><SENT sid="2614" pm="."><plain>255ZuchnerSVanceJM Mechanisms of disease: a molecular genetic update on hereditary axonal neuropathies.Nat Clin Pract Neurol2006;2:45–5316932520 </plain></SENT>
</text></ref><ref id="b256"><text><SENT sid="2615" pm="."><plain>256CasariGRugarliE Molecular basis of inherited spastic paraplegias.Curr Opin Genet Dev2001;11:336–4211377972 </plain></SENT>
</text></ref></ref-list></SecTag><fn-group><SecTag type="COMP_INT"><fn fn-type="conflict"><p><text><SENT sid="2616" pm="."><plain>Competing interests: None. </plain></SENT>
</text></p></fn></SecTag></fn-group></back></article>
